Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Severe acute respiratory infection risk following glucocorticosteroid treatment in uncomplicated influenza-like illness resulting from pH1N1 influenza infection: a case control study

Fig. 2

panel a the sARI case number of Interval from glucocorticosteroids used to sARI onset among 17 sARI patients who used the glucocorticosteroids before sARI (by 8 h), panel b the median pMEWS score and 75 and 25% precentile distribution among 17 sARI patients who used the glucocorticosteroids before sARI (by 8 h), panel c the sARI case number of Interval from equivalent assigned glucocorticosteroids use to sARI onset among 33 sARI patients who not used the glucocorticosteroids before sARI (by 8 h), panel d the median pMEWS score and 75 and 25% precentile distribution among 33 sARI patients who not used the glucocorticosteroids before sARI (by 8 h)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us